Literature DB >> 19396179

A new screening assay for allosteric inhibitors of cSrc.

Jeffrey R Simard1, Sabine Klüter, Christian Grütter, Matthäus Getlik, Matthias Rabiller, Haridas B Rode, Daniel Rauh.   

Abstract

Targeting kinases outside the highly conserved ATP pocket is thought to be a promising strategy for overcoming bottlenecks in kinase inhibitor research, such as limited selectivity and drug resistance. Here we report the development and application of a direct binding assay to detect small molecules that stabilize the inactive conformation of the tyrosine kinase cSrc. Protein X-ray crystallography validated the assay results and confirmed an exclusively allosteric binding mode.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19396179     DOI: 10.1038/nchembio.162

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  21 in total

Review 1.  A renaissance for SRC.

Authors:  Timothy J Yeatman
Journal:  Nat Rev Cancer       Date:  2004-06       Impact factor: 60.716

2.  Classifying protein kinase structures guides use of ligand-selectivity profiles to predict inactive conformations: structure of lck/imatinib complex.

Authors:  Marc D Jacobs; Paul R Caron; Brian J Hare
Journal:  Proteins       Date:  2008-03

3.  1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors.

Authors:  J Dumas; H Hatoum-Mokdad; R Sibley; B Riedl; W J Scott; M K Monahan; T B Lowinger; C Brennan; R Natero; T Turner; J S Johnson; R Schoenleber; A Bhargava; S M Wilhelm; T J Housley; G E Ranges; A Shrikhande
Journal:  Bioorg Med Chem Lett       Date:  2000-09-18       Impact factor: 2.823

4.  Small-molecule inhibitors binding to protein kinases. Part I: exceptions from the traditional pharmacophore approach of type I inhibition.

Authors:  Ac Backes; B Zech; B Felber; B Klebl; G Müller
Journal:  Expert Opin Drug Discov       Date:  2008-12       Impact factor: 6.098

Review 5.  Strategies to overcome resistance to targeted protein kinase inhibitors.

Authors:  Henrik Daub; Katja Specht; Axel Ullrich
Journal:  Nat Rev Drug Discov       Date:  2004-12       Impact factor: 84.694

6.  A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells.

Authors:  Edgar R Wood; Anne T Truesdale; Octerloney B McDonald; Derek Yuan; Anne Hassell; Scott H Dickerson; Byron Ellis; Christopher Pennisi; Earnest Horne; Karen Lackey; Krystal J Alligood; David W Rusnak; Tona M Gilmer; Lisa Shewchuk
Journal:  Cancer Res       Date:  2004-09-15       Impact factor: 12.701

7.  Structural insights into how irreversible inhibitors can overcome drug resistance in EGFR.

Authors:  Anja Michalczyk; Sabine Klüter; Haridas B Rode; Jeffrey R Simard; Christian Grütter; Matthias Rabiller; Daniel Rauh
Journal:  Bioorg Med Chem       Date:  2008-02-20       Impact factor: 3.641

8.  Structure-activity relationships of the p38alpha MAP kinase inhibitor 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naph- thalen-1-yl]urea (BIRB 796).

Authors:  John Regan; Alison Capolino; Pier F Cirillo; Thomas Gilmore; Anne G Graham; Eugene Hickey; Rachel R Kroe; Jeffrey Madwed; Monica Moriak; Richard Nelson; Christopher A Pargellis; Alan Swinamer; Carol Torcellini; Michele Tsang; Neil Moss
Journal:  J Med Chem       Date:  2003-10-23       Impact factor: 7.446

9.  Small molecule recognition of c-Src via the Imatinib-binding conformation.

Authors:  Arvin C Dar; Michael S Lopez; Kevan M Shokat
Journal:  Chem Biol       Date:  2008-10-20

10.  Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site.

Authors:  Christopher Pargellis; Liang Tong; Laurie Churchill; Pier F Cirillo; Thomas Gilmore; Anne G Graham; Peter M Grob; Eugene R Hickey; Neil Moss; Susan Pav; John Regan
Journal:  Nat Struct Biol       Date:  2002-04
View more
  27 in total

1.  Development of an online p38α mitogen-activated protein kinase binding assay and integration of LC-HR-MS.

Authors:  David Falck; Jon S B de Vlieger; Wilfried M A Niessen; Jeroen Kool; Maarten Honing; Martin Giera; Hubertus Irth
Journal:  Anal Bioanal Chem       Date:  2010-08-22       Impact factor: 4.142

2.  Affinity reagents that target a specific inactive form of protein kinases.

Authors:  Pratistha Ranjitkar; Amanda M Brock; Dustin J Maly
Journal:  Chem Biol       Date:  2010-02-26

Review 3.  Mechanisms of drug resistance in kinases.

Authors:  Rina Barouch-Bentov; Karsten Sauer
Journal:  Expert Opin Investig Drugs       Date:  2011-02       Impact factor: 6.206

4.  Natural-product-derived fragments for fragment-based ligand discovery.

Authors:  Björn Over; Stefan Wetzel; Christian Grütter; Yasushi Nakai; Steffen Renner; Daniel Rauh; Herbert Waldmann
Journal:  Nat Chem       Date:  2012-12-02       Impact factor: 24.427

5.  A Back-to-Front Fragment-Based Drug Design Search Strategy Targeting the DFG-Out Pocket of Protein Tyrosine Kinases.

Authors:  Hidehisa Iwata; Hideyuki Oki; Kengo Okada; Terufumi Takagi; Michiko Tawada; Yasushi Miyazaki; Shinichi Imamura; Akira Hori; J David Lawson; Mark S Hixon; Hiroyuki Kimura; Hiroshi Miki
Journal:  ACS Med Chem Lett       Date:  2012-02-28       Impact factor: 4.345

6.  Distinct binding mode of multikinase inhibitor lenvatinib revealed by biochemical characterization.

Authors:  Kiyoshi Okamoto; Megumi Ikemori-Kawada; Anja Jestel; Konstanze von König; Yasuhiro Funahashi; Tomohiro Matsushima; Akihiko Tsuruoka; Atsushi Inoue; Junji Matsui
Journal:  ACS Med Chem Lett       Date:  2014-11-17       Impact factor: 4.345

7.  Discovery of GNF-5837, a Selective TRK Inhibitor with Efficacy in Rodent Cancer Tumor Models.

Authors:  Pam Albaugh; Yi Fan; Yuan Mi; Fangxian Sun; Francisco Adrian; Nanxin Li; Yong Jia; Yelena Sarkisova; Andreas Kreusch; Tami Hood; Min Lu; Guoxun Liu; Shenlin Huang; Zuosheng Liu; Jon Loren; Tove Tuntland; Donald S Karanewsky; H Martin Seidel; Valentina Molteni
Journal:  ACS Med Chem Lett       Date:  2012-01-01       Impact factor: 4.345

8.  A framework for identification of actionable cancer genome dependencies in small cell lung cancer.

Authors:  Martin L Sos; Felix Dietlein; Martin Peifer; Jakob Schöttle; Hyatt Balke-Want; Christian Müller; Mirjam Koker; André Richters; Stefanie Heynck; Florian Malchers; Johannes M Heuckmann; Danila Seidel; Patrick A Eyers; Roland T Ullrich; Andrey P Antonchick; Viktor V Vintonyak; Peter M Schneider; Takashi Ninomiya; Herbert Waldmann; Reinhard Büttner; Daniel Rauh; Lukas C Heukamp; Roman K Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-03       Impact factor: 11.205

Review 9.  Monitoring protein interactions and dynamics with solvatochromic fluorophores.

Authors:  Galen S Loving; Matthieu Sainlos; Barbara Imperiali
Journal:  Trends Biotechnol       Date:  2009-12-03       Impact factor: 19.536

10.  Assessing the similarity of ligand binding conformations with the Contact Mode Score.

Authors:  Yun Ding; Ye Fang; Juana Moreno; J Ramanujam; Mark Jarrell; Michal Brylinski
Journal:  Comput Biol Chem       Date:  2016-09-06       Impact factor: 2.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.